Register
Login:
Share:
Email Facebook Twitter


ETF Securities experts James Butterfill and Townsend Lansing: did you know you can go long and short on ETF's?


Clinigen Share Price (CLIN)



Share Price Information for Clinigen (CLIN)


Share Price: 1,061.00Bid: 1,061.00Ask: 1,062.00Change: 0.00 (0.00%)No Movement on Clinigen
Spread: 1.00Spread as %: 0.09%Open: 1,047.00High: 1,068.00Low: 1,036.00Yesterday’s Close: 1,061.00

Clinigen Group Plc Ord 0.1P

Clinigen is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share
Clinigen is part of the Household Utilities sector






Share Price SpacerPrice
1061.00

Share Price SpacerBid
1061.00

Share Price SpacerAsk
1062.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
497,224

Share Price SpacerOpen
1,047.00

Share Price SpacerHigh
1,068.00

Share Price SpacerLow
1,036.00

Share Price SpacerClose
1,061.00

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 115.17m £1,221.90m 2,000

52 Week High 1,149.00 52 Week High Date 29-AUG-2017
52 Week Low 674.00 52 Week Low Date 27-SEP-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
1,266 266,034 195,807 89.160 11.90 3.60 0.34


London South East Users info for Clinigen




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Sep-17
17:13:08
1,058.9712
1,770
Sell* 
1,061.00
1,062.00
18.74k
Trade Type:
Ordinary
Bargain conditions apply

22-Sep-17
17:07:06
1,056.5761
12,037
Sell* 
1,061.00
1,062.00
127.18k
Trade Type:
Ordinary
Bargain conditions apply

22-Sep-17
17:08:00
1,058.8047
68
Sell* 
1,061.00
1,062.00
719.99
Trade Type:
Ordinary
Bargain conditions apply




View more Clinigen trades >>

Directors Deals for Clinigen (CLIN)
Trade DateActionNotifierPriceCurrencyAmountHolding
28-Jun-17Sell
Trade Notifier Information for Clinigen Group
John Bacon held the position of Non-Executive Director at Clinigen Group at the time of this trade.
 John Bacon
842.5GBX200,000530767
22-Jun-17Sell
Trade Notifier Information for Clinigen Group
Peter Allen held the position of Non-Executive Chairman at Clinigen Group at the time of this trade.
 Peter Allen
875GBX500,0000
04-May-17Transfer From
Trade Notifier Information for Clinigen Group
Peter George held the position of CEO at Clinigen Group at the time of this trade.
 Peter George
043,0003314242
View more Clinigen directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Wed 22:33finnharps112001,034.00No Opinion
rob....around!!!
Wed 22:32finnharps1Bought1,034.00No Opinion
At 976 and sold out at 1130 approx, have bought back in at 1025 hoping it might rise again but slow after Quantum purchase....AGM on 28th which might push it on a bit. This will hit up rob1200 + is just when ??? GLA
13 Sep '17CrystalBallBrokeRE: Clinigen1,060.00No Opinion
not a single post here about todays offer/deal? i am surprised
11 Sep '17robinsClinigen1,115.00No Opinion
I am a Quantum shareholder and just wondered if any of you think an offer for our company will be made? Just asking.
5 Sep '17TradeUpRE: Re: Lazy1,139.00No Opinion
Love it!

Cheers
5 Sep '17robinsRe: Lazy1,139.00No Opinion
I think your company is trying to get a smaller company on the cheap.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Clinigen (CLIN) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.